Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
Seoul National University (2015) Human melasma patients (n=62) 0.05% topical serum 12 weeks Tyrosinase modulation + turnover 21.3% MASI reduction, 4.2-unit L* increase Gradual brightening without rebound. Best for maint…
Source: realpeptides.coComparison
GHK-Cu (200–300 mcg topical) Activates lysyl oxidase via copper delivery; upregulates COL1A1 and ELN transcription; inhibits MMPs 14–22% improvement in cutometry elasticity parameters at 8–12 weeks (multiple RCTs) 8–12 …
Source: realpeptides.coComparison
GHK-Cu (2%) TGF-beta pathway activation, MMP downregulation 70% increase in collagen density at 12 weeks (JDD 2012) Low. Minimal irritation reported 8–12 weeks for visible reduction in fine lines Best option for sensiti…
Source: realpeptides.coComparison
GHK-Cu Copper-binding tripeptide activating collagen genes (COL1A1, COL3A1) + antioxidant enzyme upregulation Dermal thickening, wound healing, reduction of photoaging markers N/A (baseline compound) Daily (topical) or …
Source: realpeptides.coComparison
Melanin Reduction (12 weeks) 35–48% 50–62% 55–70% Combination with niacinamide or retinol produces additive effects. Not synergistic, but meaningfully stronger than monotherapy Irritation Risk Low (5–8% users) Low-Moder…
Source: realpeptides.coComparison
Split-face RCT (2012, J Drugs Dermatol) 20 subjects, aged 50–62 Ultrasound skin density, profilometry wrinkle depth 18% density increase, 23% thickness increase vs baseline Methodologically sound; objective measurements…
Source: realpeptides.coComparison
The peptide category isn't monolithic. Different compounds work through entirely different mechanisms, and understanding how GHK-Cu helps skin aging compared to alternatives matters when choosing a protocol. GHK-Cu Acti…
Source: realpeptides.coComparison
Topical cream (2–3%) Applied twice daily 8–12 weeks 15–20% increase in dermal collagen after 12 weeks (ultrasound-measured) Penetration depth. Effectiveness depends on formulation and skin barrier integrity Works for mi…
Source: realpeptides.coComparison
Hydroquinone remains the gold standard for treating hyperpigmentation in clinical dermatology, with concentrations of 4% producing 60–70% improvement in melasma severity over 12 weeks. It works by cytotoxic inhibition o…
Source: realpeptides.coComparison
GHK-Cu's effectiveness depends entirely on whether it reaches viable dermal fibroblasts. Fine lines form in the papillary dermis. The upper 0.3–0.6mm layer where collagen density declines with age and photodamage. If th…
Source: realpeptides.coComparison
GHK-Cu (topical) Collagen synthesis upregulation + MMP modulation Multiple RCTs, meta-analysis shows consistent benefit $30-80/month 30-40% in 12 weeks Strong first-line option. Evidence-based, safe, cost-effective for …
Source: realpeptides.coComparison
GHK-Cu Peptide (0.05–0.1%) Activates TGF-β signaling in fibroblasts; increases collagen synthesis and cross-linking 60–70% increase in procollagen mRNA within 48 hours (in vitro); 31% wrinkle depth reduction at 12 weeks…
Source: realpeptides.coComparison
Conservative management (rest, PT) Reduces mechanical stress, promotes natural healing Red-red: 60–70% success; Red-white: 30–40%; White-white: <5% 6–12 weeks High (multiple RCTs) First-line for small peripheral tears; …
Source: realpeptides.coComparison
GHK-Cu peptide (subcutaneous or topical) Collagen synthesis activation, NF-κB inhibition, copper delivery to cartilage Preclinical (animal + in vitro studies only) 4–8 weeks (subjective reports; not clinically validated…
Source: realpeptides.coComparison
GHK-Cu is effective topically because its molecular weight (340 Da) falls below the 500 Da threshold for passive diffusion through the stratum corneum. That means it doesn't require microneedling, liposomal encapsulatio…
Source: realpeptides.coComparison
GHK-Cu isn't the only peptide studied for scalp inflammation. But it's one of the few with direct evidence in hair follicle preservation. Here's how it compares to alternatives often mentioned in regenerative protocols.…
Source: realpeptides.coComparison
The evidence base for GHK-Cu in telogen effluvium is weaker than for androgenetic alopecia. A 2007 study published in Advances in Therapy evaluated a copper-peptide complex (not pure GHK-Cu, but a proprietary blend) in …
Source: realpeptides.coComparison
Minoxidil 5% Opens ATP-sensitive potassium channels; increases blood flow Multiple RCTs; FDA-approved 3–4 months Gold standard for both androgenetic alopecia and telogen effluvium—proven efficacy GHK-Cu (topical) Reduce…
Source: realpeptides.coComparison
Androgenetic alopecia research has long centered on two mechanisms: vasodilation (minoxidil) and DHT inhibition (finasteride). GHK-Cu works through a third, structurally distinct pathway. Extracellular matrix remodeling…
Source: realpeptides.coComparison
Before interpreting any peptide study, understand what the methodology can and cannot prove. Isolated fibroblast culture 1–100 nM for 24–72 hours Collagen mRNA (qRT-PCR) or procollagen protein (ELISA) High. Direct measu…
Source: realpeptides.co